Clenziderm Pore Therapy
NDC Package 62032-110-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Clenziderm Pore Therapy is use AM and PMwet facegently massage product all over face for 20–30 seconds avoiding eye arearinse thoroughly and pat drywait 10–15 minutes to allow skin to dry completely. Marketed by Omp, Inc., this product is identified by NDC 62032-110 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
62032-110-60
Package Description
118 mL in 1 BOTTLE, PLASTIC
Product Code
62032-110
11-Digit Billing Format
62032011060
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Clenziderm Pore Therapy Acne Treatment
Dosage Form
-
Usage Information
Use AM and PMwet facegently massage product all over face for 20–30 seconds avoiding eye arearinse thoroughly and pat drywait 10–15 minutes to allow skin to dry completely. cleanse the skin thoroughly before applying medicationcover the entire affected area with a thin layer one to three times dailybecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day. clean the skin thoroughly before applying this productcover the entire affected area with a thin layer one to three times dailybecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other dayif going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

Regulatory & Marketing

Labeler Name
Omp, Inc.
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-01-2007
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62032-110-60 identifies a specific commercial package of 118 ml in 1 bottle, plastic of Clenziderm Pore Therapy Acne Treatment, labeled by Omp, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Omp, Inc. on February 01, 2007. The current certification is valid through December 31, 2017.

How is this Omp, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62032011060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62032-110-60
11-Digit CMS (5-4-2)
62032-0110-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.